INO
Price
$1.54
Change
-$0.12 (-7.23%)
Updated
Apr 4, 03:37 PM (EDT)
Capitalization
58.3M
IRD
Price
$0.90
Change
-$0.08 (-8.16%)
Updated
Apr 4, 02:38 PM (EDT)
Capitalization
44.45M
Ad is loading...

INO vs IRD

Header iconINO vs IRD Comparison
Open Charts INO vs IRDBanner chart's image
Inovio Pharmaceuticals
Price$1.54
Change-$0.12 (-7.23%)
Volume$4.1K
Capitalization58.3M
Opus Genetics
Price$0.90
Change-$0.08 (-8.16%)
Volume$2K
Capitalization44.45M
INO vs IRD Comparison Chart
Loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INO vs. IRD commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INO is a Hold and IRD is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (INO: $1.66 vs. IRD: $0.98)
Brand notoriety: INO: Notable vs. IRD: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INO: 0% vs. IRD: 159%
Market capitalization -- INO: $58.3M vs. IRD: $44.45M
INO [@Biotechnology] is valued at $58.3M. IRD’s [@Biotechnology] market capitalization is $44.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INO’s FA Score shows that 0 FA rating(s) are green whileIRD’s FA Score has 0 green FA rating(s).

  • INO’s FA Score: 0 green, 5 red.
  • IRD’s FA Score: 0 green, 5 red.
According to our system of comparison, both INO and IRD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INO’s TA Score shows that 4 TA indicator(s) are bullish while IRD’s TA Score has 2 bullish TA indicator(s).

  • INO’s TA Score: 4 bullish, 6 bearish.
  • IRD’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, INO is a better buy in the short-term than IRD.

Price Growth

INO (@Biotechnology) experienced а -5.68% price change this week, while IRD (@Biotechnology) price change was -1.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.29%. For the same industry, the average monthly price growth was -17.13%, and the average quarterly price growth was -18.92%.

Reported Earning Dates

INO is expected to report earnings on May 08, 2024.

Industries' Descriptions

@Biotechnology (-11.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INO($58.3M) has a higher market cap than IRD($44.4M). INO YTD gains are higher at: -6.742 vs. IRD (-17.655). IRD has higher annual earnings (EBITDA): -28.52M vs. INO (-109.89M). INO has more cash in the bank: 84.8M vs. IRD (36.6M). IRD has higher revenues than INO: IRD (8.38M) vs INO (203K).
INOIRDINO / IRD
Capitalization58.3M44.4M131%
EBITDA-109.89M-28.52M385%
Gain YTD-6.742-17.65538%
P/E RatioN/AN/A-
Revenue203K8.38M2%
Total Cash84.8M36.6M232%
Total Debt12.4MN/A-
FUNDAMENTALS RATINGS
INO vs IRD: Fundamental Ratings
INO
IRD
OUTLOOK RATING
1..100
5380
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9085
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INO's Valuation (60) in the Medical Specialties industry is in the same range as IRD (62) in the null industry. This means that INO’s stock grew similarly to IRD’s over the last 12 months.

INO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as IRD (100) in the null industry. This means that INO’s stock grew similarly to IRD’s over the last 12 months.

INO's SMR Rating (98) in the Medical Specialties industry is in the same range as IRD (98) in the null industry. This means that INO’s stock grew similarly to IRD’s over the last 12 months.

IRD's Price Growth Rating (85) in the null industry is in the same range as INO (90) in the Medical Specialties industry. This means that IRD’s stock grew similarly to INO’s over the last 12 months.

IRD's P/E Growth Rating (97) in the null industry is in the same range as INO (100) in the Medical Specialties industry. This means that IRD’s stock grew similarly to INO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INOIRD
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 19 days ago
77%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VVV34.47-1.37
-3.82%
Valvoline
FBIO1.52-0.09
-5.59%
Fortress Biotech
FRBA13.89-0.97
-6.53%
First Bank
USB38.79-4.22
-9.81%
US Bancorp
CIFR2.31-0.34
-12.83%
Cipher Mining

IRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRD has been loosely correlated with ARRY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IRD jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRD
1D Price
Change %
IRD100%
+5.07%
ARRY - IRD
35%
Loosely correlated
-10.32%
TERN - IRD
34%
Loosely correlated
-6.43%
INO - IRD
33%
Poorly correlated
N/A
MURA - IRD
32%
Poorly correlated
-6.82%
VIR - IRD
32%
Poorly correlated
-8.02%
More